Dr. Ranee Mehra, MD
Claim this profileUniversity of Maryland/Greenebaum Cancer Center
Expert in Cancer
Expert in Squamous Cell Carcinoma
21 reported clinical trials
54 drugs studied
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
metastatic
2Squamous Cell Carcinoma
Global LeaderStage IV
Stage III
metastatic
Affiliated Hospitals
Clinical Trials Ranee Mehra, MD is currently running
ADT + Pembrolizumab
for Salivary Gland Cancer
A Phase II, multi-center, single-arm, non-blinded study combining androgen deprivation therapy (ADT) and pembrolizumab for patients with metastatic or locally recurrent androgen receptor-positive salivary gland carcinoma, not amenable to surgery or radiation.
Recruiting1 award Phase 221 criteria
TAK-676 + Pembrolizumab
for Metastatic Cancer
This trial is testing a new drug called dazostinag, alone and with another drug called pembrolizumab, to treat people with advanced solid tumors. It focuses on patients with specific types of head and neck cancer and colorectal cancer who have few other treatment options. The goal is to find a safe dose and see if the combination can help the immune system fight the cancer more effectively.
Recruiting2 awards Phase 1 & 210 criteria
More about Ranee Mehra, MD
Clinical Trial Related5 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Ranee Mehra, MD has experience with
- Pembrolizumab
- Cisplatin
- Evorpacept
- Nivolumab
- Cetuximab
- Radiation Therapy
Breakdown of trials Ranee Mehra, MD has run
Cancer
Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Head and Neck Cancers
Non-Small Cell Lung Cancer
- Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab
- TOS-358 for Cancer
- GMCI + Immunotherapy for Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ranee Mehra, MD specialize in?
Ranee Mehra, MD focuses on Cancer and Squamous Cell Carcinoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Ranee Mehra, MD currently recruiting for clinical trials?
Yes, Ranee Mehra, MD is currently recruiting for 8 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Ranee Mehra, MD has studied deeply?
Yes, Ranee Mehra, MD has studied treatments such as Pembrolizumab, Cisplatin, Evorpacept.
What is the best way to schedule an appointment with Ranee Mehra, MD?
Apply for one of the trials that Ranee Mehra, MD is conducting.
What is the office address of Ranee Mehra, MD?
The office of Ranee Mehra, MD is located at: University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland 21201 United States. This is the address for their practice at the University of Maryland/Greenebaum Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.